Oracle Investment Management as of Dec. 31, 2012
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 21 positions in its portfolio as reported in the December 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quidel Corporation | 17.5 | $61M | 3.3M | 18.67 | |
| Thoratec Corporation | 15.9 | $56M | 1.5M | 37.52 | |
| Acorda Therapeutics | 14.1 | $50M | 2.0M | 24.86 | |
| Opko Health (OPK) | 6.9 | $24M | 5.1M | 4.81 | |
| Accuray Incorporated (ARAY) | 5.3 | $19M | 2.9M | 6.43 | |
| MAP Pharmaceuticals | 4.9 | $17M | 1.1M | 15.65 | |
| GTx | 4.8 | $17M | 4.0M | 4.20 | |
| Hansen Medical | 4.7 | $17M | 8.0M | 2.08 | |
| Accelr8 Technology Corporation | 4.3 | $15M | 2.2M | 7.03 | |
| MAKO Surgical | 3.9 | $14M | 1.1M | 12.85 | |
| Gentiva Health Services | 3.7 | $13M | 1.3M | 10.05 | |
| Tesaro | 3.2 | $11M | 657k | 16.95 | |
| Ironwood Pharmaceuticals (IRWD) | 2.4 | $8.4M | 758k | 11.08 | |
| Transition Therapeutics | 2.3 | $8.1M | 3.6M | 2.26 | |
| Achillion Pharmaceuticals | 2.0 | $7.1M | 891k | 8.01 | |
| NxStage Medical | 1.6 | $5.8M | 516k | 11.25 | |
| Metabolix | 0.7 | $2.5M | 1.7M | 1.48 | |
| Vivus | 0.7 | $2.3M | 174k | 13.42 | |
| Health Net | 0.5 | $1.8M | 75k | 24.30 | |
| Biogen Idec (BIIB) | 0.5 | $1.8M | 12k | 146.37 | |
| Ladenburg Thalmann Financial Services | 0.1 | $280k | 200k | 1.40 |
